We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $28.5B Turnover 25.57%
1-Year Est. Return 37.56%
 

Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+37.56%
3 Year Est. Return
+139.56%
5 Year Est. Return
+184.28%
10 Year Est. Return
+661.21%
AUM
$28.5B
AUM Growth
+$740M
Cap. Flow
+$898M
Cap. Flow %
3.15%
Top 10 Hldgs %
30.41%
Holding
1,052
New
118
Increased
279
Reduced
477
Closed
151
Avg Time Held
2.1 years
Top 10 Avg Time Held
4.1 years
Top 20 Avg Time Held
2.6 years

Top Buys

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$265M
2
CMI icon
Cummins
CMI
+$251M
3
F icon
Ford
F
+$188M
4
HUM icon
Humana
HUM
+$172M
5
MSFT icon
Microsoft
MSFT
+$167M

Sector Composition

Rank Sector Weight
1 Technology 34.64%
2 Financials 12.47%
3 Consumer Discretionary 12.33%
4 Industrials 11.08%
5 Healthcare 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PRTA icon
351
Prothena
PRTA
$419M
$7.24M 0.03%
863,893
-102,095
-11% -$912K
2025 Q1
6 quarters
ADNT icon
352
Adient
ADNT
$1.2B
$7.24M 0.03%
429,755
+378,070
+731% +$7.28M
2026 Q2
1 quarter
HG icon
353
Hamilton Insurance Group
HG
$3.78B
$7.18M 0.03%
217,416
-76,138
-26% -$2.66M
2025 Q4
3 quarters
MMI icon
354
Marcus & Millichap
MMI
$936M
$7.17M 0.03%
252,173
-20,574
-8% -$640K
2025 Q4
3 quarters
CTRN icon
355
Citi Trends
CTRN
$364M
$7.17M 0.03%
138,991
-4,043
-3% -$260K
2025 Q3
4 quarters
AR icon
356
Antero Resources
AR
$11.6B
$7.11M 0.02%
212,981
-184,283
-46% -$6.65M
2026 Q1
2 quarters
FELE icon
357
Franklin Electric
FELE
$4.34B
$7.08M 0.02%
73,829
+441
+0.6% +$45.1K
2025 Q1
6 quarters
BANC icon
358
Banc of California
BANC
$2.83B
$7.05M 0.02%
409,138
-112,047
-21% -$2.16M
2025 Q4
3 quarters
HOG icon
359
Harley-Davidson
HOG
$3.27B
$7.03M 0.02%
287,652
+24,849
+9% +$657K
2026 Q1
2 quarters
GCO icon
360
Genesco
GCO
$384M
$7.02M 0.02%
205,650
-77,190
-27% -$2.72M
2020 Q4
23 quarters
ALX icon
361
Alexander's
ALX
$1.25B
$6.96M 0.02%
28,250
-24
-0.1% -$6.38K
2025 Q3
4 quarters
REG icon
362
Regency Centers
REG
$13.9B
$6.95M 0.02%
96,754
-637
-0.7% -$49.2K
2023 Q1
14 quarters
GSM icon
363
Ferroglobe
GSM
$561M
$6.93M 0.02%
1,742,984
+249,709
+17% +$972K
2025 Q3
4 quarters
SMTC icon
364
Semtech
SMTC
$10.7B
$6.92M 0.02%
38,822
-11,114
-22% -$1.57M
2026 Q2
1 quarter
EQH icon
365
Equitable Holdings
EQH
$15B
$6.83M 0.02%
133,244
-347
-0.3% -$17.4K
2026 Q1
2 quarters
ETD icon
366
Ethan Allen Interiors
ETD
$441M
$6.73M 0.02%
321,727
-64,572
-17% -$1.45M
2025 Q1
6 quarters
GIC icon
367
Global Industrial
GIC
$1.78B
$6.69M 0.02%
159,450
-6,426
-4% -$243K
2025 Q1
6 quarters
SCHL icon
368
Scholastic
SCHL
$678M
$6.65M 0.02%
189,153
-41,406
-18% -$1.68M
2023 Q3
12 quarters
MYGN icon
369
Myriad Genetics
MYGN
$543M
$6.55M 0.02%
1,519,126
-372,401
-20% -$1.57M
2025 Q2
5 quarters
MOV icon
370
Movado Group
MOV
$709M
$6.53M 0.02%
196,220
-47,817
-20% -$1.71M
2022 Q2
17 quarters
GRND icon
371
Grindr
GRND
$2.62B
$6.45M 0.02%
417,759
-327,661
-44% -$5.19M
2025 Q2
5 quarters
VRDN icon
372
Viridian Therapeutics
VRDN
$3.51B
$6.39M 0.02%
310,428
+209,014
+206% +$4.46M
2026 Q2
1 quarter
PB icon
373
Prosperity Bancshares
PB
$8.76B
$6.37M 0.02%
96,180
-10,532
-10% -$760K
2025 Q1
6 quarters
AAT icon
374
American Assets Trust
AAT
$1.33B
$6.35M 0.02%
298,503
+1,065
+0.4% +$24.7K
2025 Q1
6 quarters
BBIO icon
375
BridgeBio Pharma
BBIO
$15.3B
$6.31M 0.02%
95,872
+4,688
+5% +$365K
2026 Q1
2 quarters

Similar funds

Jacobs Levy Equity Management's Q3 2026 Portfolio in Review

As of Q3 2026, Jacobs Levy Equity Management held 1,052 positions worth $28.5B, up 2.7% from $27.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jacobs Levy Equity Management deployed $898M of net new capital in Q3 2026, opening 118 new positions and adding to 279 existing holdings. Its largest new stake was Monster Beverage: 5,720,419 shares worth $238M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Atlassian, an estimated $158M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2026 buy was Monster Beverage: 5,720,419 shares worth $238M.
  • Jacobs Levy Equity Management added most to Cummins in Q3 2026, an estimated $251M increase.
  • Jacobs Levy Equity Management's biggest Q3 2026 reduction was Atlassian, cutting an estimated $158M.
  • Jacobs Levy Equity Management fully exited West Pharmaceutical in Q3 2026, selling an estimated $182M.
  • Jacobs Levy Equity Management's ten largest holdings make up 30% of its $28.5B portfolio in Q3 2026.
  • Jacobs Levy Equity Management opened 118 new positions and closed 151 in Q3 2026.
  • Jacobs Levy Equity Management's portfolio value rose 2.7% quarter-over-quarter to $28.5B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.